Clik here to view.
Nanopatch tops needles, syringes as delivery system for polio vaccine in...
A microscopic vaccine delivery platform developed by researchers at the University of Queensland has proven a more effective way to deliver a polio virus vaccine compared to needles and syringes in an...
View ArticleClik here to view.
Titan, Opiant partner to develop subcutaneous implant for opioid use disorder
Titan Pharmaceuticals (NSDQ:TTNP) and Opiant Pharmaceuticals(NSDQ:OPNT) announced this week that the companies are partnering to develop a subcutaneous implant to deliver an opioid antagonist. The pair...
View ArticleClik here to view.
AgaMatrix lands $32m loan for split
With a $32 million loan in hand, AgaMatrix said this week it plans to reorganize the companies into two entities – AgaMatrix, Inc. and WaveForm Technologies. The holding company raised $32 million from...
View ArticleClik here to view.
India pulls an about-face on Abbott’s Xience Alpine stent
India’s Department of Pharmaceuticals has stopped Abbott (NYSE:ABT) from pulling its Xience Alpine drug-eluting coronary stent from the market. The move is a reversal from the National Pharmaceutical...
View ArticleClik here to view.
Insulet looks to lure Animas users
Just days after Johnson & Johnson (NYSE:JNJ) revealed that it plans to shut down its 410-worker Animas insulin pump subsidiary, Insulet (NSDQ:PODD) said it would offer existing Animas insulin pump...
View ArticleClik here to view.
Biotronik launches trial to test new coronary drug-eluting stent
Biotronik said yesterday that it began enrolling patients in a trial designed to assess the safety and efficacy of a new coronary drug-eluting stent in de novo coronary artery lesions. The Biovitesse...
View ArticleClik here to view.
Intersect ENT touts results from pivotal study of steroid-releasing sinus...
Intersect ENT (NSDQ:XENT) touted data this week from the pivotal Resolve II trial of its investigational steroid-releasing sinus implant, Sinuva. The Phase III trial evaluated Sinuva in 300 adult...
View ArticleClik here to view.
Researchers treat first cancer patients with BTG’s microscopic, drug-loaded...
Researchers from the UCL Cancer Institute and BTG (LON:BTG) have started the first clinical trial of microscopic beads loaded with a targeted, cancer-fighting drug for patients with primary liver...
View ArticleClik here to view.
Tandem shareholders approve 1-for-10 reverse split
Tandem Diabetes Care (NSDQ:TNDM) shareholders have approved a 1-for-10 reverse stock split, the company said earlier this week, which took effect today. In a statement filed with the SEC in July, the...
View ArticleClik here to view.
Smart bandage releases medication as needed
A team of researchers from the University of Nebraska, Harvard Medical School and MIT have created a smart bandage that can be loaded with antibiotics, painkillers or other drugs and triggered by a...
View ArticleClik here to view.
Catalent launches $450m private offering
Catalent (NYSE:CTLT) said today that its subsidiary, Catalent Pharma Solutions, plans to offer $450 million in senior unsecured notes due 2026. The private offering will be used to fund, in part, the...
View ArticleClik here to view.
Study: West’s device aids in dose-sparing administration of polio vaccine
West Pharmaceutical Services (NYSE:WST) touted results today from a study showing that its ID Adapter can improve the intradermal administration of polio vaccines. The study, published in the journal...
View ArticleClik here to view.
MannKind inks $61m direct offering of common stock
MannKind (NSDQ:MNKD) said today that it inked a deal with a group of unnamed investors for a registered direct offering of 10,166,600 shares of the company’s common stock for $6.00 apiece. The $61...
View ArticleClik here to view.
Titan Pharmaceuticals treats first Parkinson’s patient with subdermal implant
Titan Pharmaceuticals (NSDQ:TTNP) has treated the first patient in a Phase I/II trial of its ropinirole implant designed to treat the signs and symptoms of idiopathic Parkinson’s disease. Ropinirole is...
View ArticleClik here to view.
Here’s how the diabetes industry’s leaders think about patient-centered R&D
Designing devices centered around patients is a goal espoused by nearly all device companies nowadays, as they aim to make products that people want to use and can incorporate into their everyday...
View ArticleClik here to view.
BioDelivery Sciences, Teva settle patent fight over opioid dependence treatment
BioDelivery Sciences (NSDQ:BDSI) said today that it inked a deal with Teva Pharmaceuticals (NYSE:TEVA) to settle claims that the generic form of BioDelivery Sciences’ Bunavail buccal film that Teva is...
View ArticleClik here to view.
European task force: Docs should favor drug-eluting stents over bioresorbable...
Physicians should not use bioresorbable scaffolds in place of current-generation drug-eluting stents, according to a report from the European Society of Cardiology and European Association of...
View ArticleClik here to view.
AcelRx shares tumble after FDA rejects Dsuvia painkiller
Shares in AcelRx Pharmaceuticals (NSDQ:ACRX) fell more than -50% this morning after the company announced that it received a complete response letter from the FDA for its Dsuvia sufentanil sublingual...
View ArticleClik here to view.
Boehringer Ingelheim, Anthem partner for largest real-world COPD trial
As part of a research collaboration launched in 2014, Boehringer Ingelheim and Anthem have partnered to study people with chronic obstructive pulmonary disease in real-world settings to assess how...
View ArticleClik here to view.
Biologics & auto-injectors: How West Pharma designs for evolving trends in...
If you’ve ever received a flu shot or taken insulin, you’ve probably used a device designed by West Pharmaceutical Services (NYSE:WST), according to VP & GM of biologics Graham Reynolds. “Probably...
View Article